100
Participants
Start Date
April 8, 2022
Primary Completion Date
October 16, 2025
Study Completion Date
October 16, 2025
MERIVA® Tablets
The treatment corresponds to 1 g / day of experimental product (corresponding to about 200 mg of curcuminoids).
Placebo Tablets
The composition of placebo includes the same components of the treatment tablets, except for the active substance.
"S.C. di Endocrinologia e Diabetologia, Policlinico Universitario Agostino Gemelli", Roma
Istituto Superiore di Sanità
OTHER
Sintesi Research Srl
INDUSTRY
Indena S.p.A
INDUSTRY